Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.22.1
Significant Accounting Policies (Tables)
3 Months Ended
Apr. 30, 2022
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of (i) cash and cash equivalents and (ii) restricted cash in the condensed consolidated statements of cash flows as of the periods presented:

 

 

 

As of April 30,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

16,465

 

 

$

21,278

 

Restricted cash

 

 

305

 

 

 

631

 

Total cash, cash equivalents and restricted cash

 

$

16,770

 

 

$

21,909

 

 

 

 

As of January 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

17,528

 

 

$

5,856

 

Restricted cash

 

 

328

 

 

 

228

 

Total cash, cash equivalents and restricted cash

 

$

17,856

 

 

$

6,084

 

Schedule of Anti-dilutive Securities Excluded from Computation of Loss Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive:

 

 

 

For the Three Months

Ended April 30,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Stock options

 

 

1,241

 

 

 

1,897

 

Restricted stock units

 

 

 

 

 

135

 

Deferred stock units

 

 

 

 

 

41

 

 

 

 

1,241

 

 

 

2,073